Cargando…
Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
Cannabinoid receptor 2 (CB(2)) is predominantly distributed in immune tissues and cells and is a promising therapeutic target for modulating inflammation. In this study we designed and synthesised a series of 2,4,6-trisubstituted 1,3,5-triazines with piperazinylalkyl or 1,2-diethoxyethane (PEG2) cha...
Autores principales: | Oyagawa, Caitlin R. M., de la Harpe, Sara M., Saroz, Yurii, Glass, Michelle, Vernall, Andrea J., Grimsey, Natasha Lillia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256112/ https://www.ncbi.nlm.nih.gov/pubmed/30524271 http://dx.doi.org/10.3389/fphar.2018.01202 |
Ejemplares similares
-
Erratum: Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
Publicado: (2019) -
Synthesis and PI 3-Kinase Inhibition Activity of Some Novel 2,4,6-Trisubstituted 1,3,5-Triazines
por: Nelson, Ronald A., et al.
Publicado: (2018) -
Design and Synthesis of New 1,3,5‐Trisubstituted Triazines for the Treatment of Cancer and Inflammation
por: Zacharie, Boulos, et al.
Publicado: (2018) -
Atom-efficient synthesis of 2,4,6-trisubstituted 1,3,5-triazines via Fe-catalyzed cyclization of aldehydes with NH(4)I as the sole nitrogen source
por: Xiao, Jiang, et al.
Publicado: (2020) -
Trisubstituted 1,3,5-Triazines as Histamine H(4) Receptor Antagonists with Promising Activity In Vivo
por: Olejarz-Maciej, Agnieszka, et al.
Publicado: (2023)